Medicines Control Authority of Zimbabwe

Public Clinical Trials Registry

List Applications   Download PDF
MRCZ/A/3180
24-05-2024

The Friendship Bench Plus trial (FB+Trial)

Combining antidepressants with psychological therapy to improve depression outcome in Zimbabwe - the Friendship Bench Plus trial (FB+Trial)

Primary Sponsor Details
University Hospital of Psychiatry and Psychotherapy Bern

Secondary Sponsor Details
Swiss National science Foundation
Rukudzo Mwamuka
Study coordinator
ruemwamuka.tsungu@gmail.com
0777065549
4 Cuba Avenue Mt Pleasant Harare
University of Bern
Dickson Chibanda
Principal Investigator
dixon.chibanda@frienshipbench.io
0712204107
4 Weale Road Milton Park
University of Zimbabwe

Zimbabwe

Foreign
Depression
Fluoxetine
40000 tablets

We will include adults ≥18 years with moderate to severe depression defined as PHQ-9 ≥ 11 who are treatment naïve to the FB at the time of recruitment.

Exclusion criteria will be: mild depression defined as PHQ-9 <11; receiving specialist mental health care including antidepressants at the time of recruitment; pregnancy (urine pregnancy test will be performed); history of serious physical health problem (kidney failure, liver failure, serious heart disease, cancer, end-stage AIDS); presenting with high suicidal risk; presenting with psychotic symptoms; or unable to comprehend the nature of the study in either English or Shona (local language).

Our primary outcome will be treatment response after four months defined as ≥ 50% improvement in the PHQ-9 score as compared to baseline

Remission after four months defined as PHQ-9<5 will be our key secondary outcome.

9.0 DESIGN OF THE TRIAL
Controlled

If controlled

Yes
No
No
No
No
No
The Friendship Bench psychological intervention
No
No
No
No
296
296
296
August 2024 to 31 December 2028